Press Release
Abcam appoints Markus Lusser as new President
Press Release
Abcam recognized by Stonewall for commitment to LGBTQ+ inclusivity
Press Release
Abcam most cited antibody supplier for IHC in 2023
Press Release
New method developed to promote best-practice evaluation of research antibodies
Press Release
Danaher to acquire Abcam for $24.00 per Share
Press Release
Lunaphore and abcam announce agreement for primary antibody validation for use on COMET™
Registered Office:
Discovery Drive, Cambridge
Biomedical Campus,
Cambridge, CB2 0AX, UK
+44 (0) 1223 696 000
VIEW PRODUCTS
© Abcam Limited. all rights reserved.
Abcam Limited is incorporated in England and Wales, its main country of operation in the UK. Use of this website is subject to our Terms and Conditions of use and our Privacy Policy. Share price and news information on this site is updated dynamically from external data feeds.
